Home / ONCO.ST : STO

AI Analysis Fundamentals Valuation Earnings Video Analysis News Similar

AI Analysis

How does ONCO.ST make money? Does ONCO.ST have pricing power? What's the Earnings Whisper? Will ONCO.ST profit more as the business scales? What is ONCO.ST's management track record? Is ONCO.ST's current price justified?

Oncopeptides AB (publ)

SEK 1.67 -$3.21 (-65.72%)

STO · 30 Oct 2026 11:59 UTC

Previous Close

SEK 1.71

Day Range

SEK 1.67SEK 1.74

Year Range

SEK 1.25SEK 6.14

Market Cap

638.01M

AVG Volume

4.11M

Trailing/Forward PE

-2.14/-

PEG ratio

0.04

Dividend Yield

Next Earnings Date

2026-11-05

Primary Exchange

Stockholm Stock Exchange

Revenue (SEK) · Q

ONCO.ST Revenue (SEK) by quarter
Period	Revenue (SEK)
26 Q2	31.1M
26 Q1	25.38M
25 Q4	18.57M
25 Q3	20.21M
25 Q2	19.18M
25 Q1	13.27M
24 Q4	9.91M
24 Q3	8.51M
24 Q2	8.15M
24 Q1	5.07M

Net Income (SEK) · Q

ONCO.ST Net Income (SEK) by quarter
Period	Net Income (SEK)
26 Q2	-54.71M
26 Q1	-32.19M
25 Q4	-65.17M
25 Q3	-60.89M
25 Q2	-62.85M
25 Q1	-60.67M
24 Q4	-83.43M
24 Q3	-60.23M
24 Q2	-73.24M
24 Q1	-67.7M

Operating Income (SEK) · Q

ONCO.ST Operating Income (SEK) by quarter
Period	Operating Income (SEK)
26 Q2	-50.96M
26 Q1	-40.7M
25 Q4	-62.38M
25 Q3	-47.05M
25 Q2	-56.23M
25 Q1	-59.84M
24 Q4	-83.33M
24 Q3	-61.25M
24 Q2	-73.27M
24 Q1	-69.12M

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (SEK) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 5 Nov 2026.

No video analysis for this stock yet. Request one from our team.

AI Analysis

Oncopeptides AB (publ)

Earnings: ONCO.ST

Video analysis: ONCO.ST

News: ONCO.ST

Similar companies